Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence
暂无分享,去创建一个
[1] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[2] Ah-Young Kwon,et al. The Prognostic Impact of HER2 Genetic and Protein Expression in Pancreatic Carcinoma—HER2 Protein and Gene in Pancreatic Cancer , 2021, Diagnostics.
[3] J. Feliu,et al. Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice? , 2021, Cancers.
[4] L. Matrisian,et al. Estimated Projection of US Cancer Incidence and Death to 2040 , 2021, JAMA network open.
[5] T. Murakawa. Past, present, and future perspectives of pulmonary metastasectomy for patients with advanced colorectal cancer , 2020, Surgery Today.
[6] E. Aranda,et al. Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer , 2020, Cancers.
[7] C. Vitellius,et al. Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinoma , 2020, Molecular Diagnosis & Therapy.
[8] F. Guerra,et al. Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] J. Kleeff,et al. Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review , 2020, Scientific Reports.
[10] B. Hankey,et al. Surveillance, Epidemiology, and End Results Program , 2020, Definitions.
[11] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[12] S. Natsugoe,et al. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[13] M. Büchler,et al. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. , 2019, JAMA surgery.
[14] J. Dunning,et al. Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial , 2019, Trials.
[15] C. Pilarsky,et al. Chemoresistance in Pancreatic Cancer , 2019, International journal of molecular sciences.
[16] N. Tsang,et al. Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact , 2019, Journal of clinical medicine.
[17] J. Cameron,et al. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[18] Song-Cheol Kim,et al. Management of isolated recurrence after surgery for pancreatic adenocarcinoma , 2019, The British journal of surgery.
[19] S. Dabernat,et al. Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma , 2019, Cancers.
[20] J. Neoptolemos,et al. Surgical and local therapeutic concepts of oligometastatic pancreatic cancer in the era of effective chemotherapy , 2019, European Surgery.
[21] D. Jäger,et al. Chemotherapy for pancreatic cancer. , 2019, Presse medicale.
[22] M. Maglione,et al. Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer , 2019, Cancers.
[23] A. Maitra,et al. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. , 2019, Gastroenterology.
[24] K. Kichikawa,et al. Prognostic factors for actual long-term survival in the era of multidisciplinary treatment for pancreatic ductal adenocarcinoma , 2018, Langenbeck's Archives of Surgery.
[25] M. Capanu,et al. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior , 2018, BMC Cancer.
[26] Zhiqiang Sun,et al. Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real‐world study , 2018, Cancer medicine.
[27] J. Joo,et al. Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma. , 2018, Clinical chemistry.
[28] Jing Guo,et al. Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients , 2018, Medicine.
[29] T. Ohtsuka,et al. Primary Recurrence in the Lung is Related to Favorable Prognosis in Patients with Pancreatic Cancer and Postoperative Recurrence , 2017, World Journal of Surgery.
[30] B. Melichar,et al. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature , 2017, World journal of gastroenterology.
[31] F. Motoi,et al. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention , 2017, Surgery Today.
[32] A. Mehrabi,et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis , 2017, World journal of gastroenterology.
[33] Y. Maehara,et al. Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer. , 2017, Anticancer research.
[34] M. Büchler,et al. Radical surgery of oligometastatic pancreatic cancer , 2016 .
[35] Valérie Taly,et al. Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker , 2016, Clinical Cancer Research.
[36] J. Werner,et al. Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[37] J. Fontaine,et al. Pulmonary metastasectomy for suspected pancreaticobiliary cancer. , 2016, The Journal of thoracic and cardiovascular surgery.
[38] I. Juan,et al. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis—a case control study , 2016, Oncotarget.
[39] Taesung Park,et al. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value , 2016, Journal of gastroenterology and hepatology.
[40] A. Maitra,et al. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] H. Zeh,et al. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas , 2015, Journal of surgical oncology.
[42] W. Scheithauer,et al. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. , 2015, Journal of the National Cancer Institute.
[43] R. Weichselbaum,et al. 14q32-encoded microRNAs mediate an oligometastatic phenotype , 2015, Oncotarget.
[44] V. Brouste,et al. Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases , 2014, PloS one.
[45] T. Treasure. Pulmonary Metastasectomy for Colorectal Cancer: Recent Reports Prompt a Review of the Available Evidence , 2014, Current Colorectal Cancer Reports.
[46] M. Yoshimura,et al. Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer , 2014, Strahlentherapie und Onkologie.
[47] O. Petrenko,et al. Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas , 2014, Proceedings of the National Academy of Sciences.
[48] David Goldstein,et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.
[49] J. Pearson,et al. Clinical and molecular characterization of HER2 amplified-pancreatic cancer , 2013, Genome Medicine.
[50] J. Gaughan,et al. Patterns of recurrence and outcomes in pancreatic cancer. , 2013 .
[51] C. Combescure,et al. Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.
[52] V. Heinemann,et al. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy , 2013, Journal of Cancer Research and Clinical Oncology.
[53] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[54] P. Kozuch,et al. Case Report: Long-Term Survival in Patients with Initial Lung-Only Metastasis from Pancreatic Adenocarcinoma , 2012, Journal of Gastrointestinal Cancer.
[55] Jeffrey E. Lee,et al. Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection , 2012, Journal of Gastrointestinal Surgery.
[56] M. Kage,et al. Metastatic pulmonary adenocarcinoma 13 years after curative resection for pancreatic cancer: report of a case and review of Japanese literature. , 2012, JOP : Journal of the pancreas.
[57] R. Weichselbaum,et al. MicroRNA Expression Characterizes Oligometastasis(es) , 2011, PloS one.
[58] J. Cameron,et al. Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival , 2011, Journal of Gastrointestinal Surgery.
[59] Pierre Michel,et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.
[60] M. Hashizume,et al. MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer , 2011, Annals of Surgical Oncology.
[61] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[62] V. Jooste,et al. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study , 2010, Gut.
[63] K. Ohuchida,et al. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation , 2010, Molecular Cancer.
[64] Giovanni Parmigiani,et al. SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer , 2009, Clinical Cancer Research.
[65] Alison P. Klein,et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] Sunil Krishnan,et al. Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma , 2009, Annals of Surgical Oncology.
[67] M. Choti,et al. Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis , 2007, Annals of Surgical Oncology.
[68] H. Friess,et al. Surgery for Recurrent Pancreatic Ductal Adenocarcinoma , 2007, Annals of surgery.
[69] C. Iacobuzio-Donahue,et al. Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy , 2005, Cancer biology & therapy.
[70] Y. Ohno,et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. , 2004, The Annals of thoracic surgery.
[71] B. Eisenberg,et al. Is Reporting of Recurrence Data Important in Pancreatic Cancer? , 2004, Annals of Surgical Oncology.
[72] J. Cameron,et al. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[73] H. Ueno,et al. Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy , 2000, Oncology.
[74] M. Koike,et al. Hematogenous Metastases of Pancreatic Ductal Carcinoma , 1995, Pancreas.
[75] Atsushi Fujii,et al. Patients with Lung Recurrence after Curative Resection forPancreatic Ductal Adenocarcinoma Have a Better Prognosis than Those with Recurrence at Other Sites , 2017 .
[76] N. Pavlakis,et al. Patterns and Determinants of Recurrence for Pancreatic Ductal Adenocarcinoma after Resection , 2017 .
[77] E. Diamandis,et al. Pancreatic cancer. , 2013, Clinical chemistry.
[78] H. Taubert,et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival , 2010, International journal of cancer.
[79] W. Leach. Carcinoma of the pancreas; a clinical and pathologic analysis of 39 autopsied cases. , 1950, The American journal of pathology.